跳至主要内容
临床试验/NCT05492721
NCT05492721已完成3 期

Comparing Tissue Adhesives in Port Site Closure: A Randomized Controlled Trial

The University of Texas Health Science Center, Houston1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2022年6月29日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
180
试验地点
1
主要终点
proportion of patients who develop contact dermatitis

研究概览

简要总结

This is a multi-center randomized controlled trial to evaluate two different methods of reinforcing surgical port site closure: 2-Octylcyanoacrylate and n-butyl-2-cyanoacrylate.

详细描述

Study Design

This is a multi-center randomized controlled trial to evaluate two different methods of reinforcing surgical port site closure: 2-Octylcyanoacrylate and n-butyl-2-cyanoacrylate.

Methods

Inclusion Criteria All adult patients undergoing an elective laparoscopic or robotic abdominal surgery with the Minimally Invasive Surgeons of Texas (MIST) either at Texas Medical Center or Sugar Land will be eligible.

Exclusion criteria

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Outcome assessor does not know which glue was used

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 or older
  • undergoing an elective laparoscopic or robotic abdominal surgery

排除标准

  • Patients unlikely to follow-up (live out of state, unable to be reached by phone or email)
  • Patients with a known allergy to 2-Octylcyanoacrylate or N-butyl-2-cyanoacrylate.

研究组 & 干预措施

Dermabond (2-Octylcyanoacrylate)

Active Comparator

Dermabond over incisions

干预措施: Dermabond (2-Octylcyanoacrylate) (Device)

Swiftset (N-butyl-2-cyanoacrylate)

Active Comparator

Swiftset over incisions

干预措施: Swiftset (N-butyl-2-cyanoacrylate) (Device)

Liquiband (2-Octylcyanoacrylate)

Active Comparator

Liquiband over incisions

干预措施: Liquiband (2-Octylcyanoacrylate) (Device)

结局指标

主要结局

proportion of patients who develop contact dermatitis

时间窗: 6 weeks

erythema or rash around incisions

次要结局

  • proportion of patients with surgical site infection(6 weeks)
  • mean diameter of erythema(6 weeks)
  • proportion of patients with wound dehiscence(6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Julie Holihan

Assistant Professor of Surgery

The University of Texas Health Science Center, Houston

研究点 (1)

Loading locations...

相似试验